FDA Inspection 915225 — Pfizer, Inc.

Pfizer, Inc. — FEI 1211022

The FDA completed an inspection of Pfizer, Inc. on Jan 23, 2015 in Groton, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 23, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Groton, CT (United States)

Citations

IDCFRDescription
189021 CFR 211.165(e)Test methods
240121 CFR 211.194(a)(4)Complete Test Data